AAAAAA

   
Results: 1-8 |
Results: 8

Authors: PELTEKIAN KM BAILEY R BAIN V MA M SHERKER A STALGIS C
Citation: Km. Peltekian et al., HEPATITIS-C GENOTYPE-1 (HCV G-1) VIRAL KINETICS DURING COMBINATION THERAPY WITH RIBAVIRIN (RIB) AND VARIOUS INDUCTION DOSES OF INTERFERON-ALPHA (IFN), Hepatology, 28(4), 1998, pp. 196-196

Authors: LURIE Y ESTEBANMUR R BUTI M ESTEBANMUR JI STALGIS C
Citation: Y. Lurie et al., DAILY THERAPY FOR 12 WEEKS WITH IFN-ALPHA-2B PLUS RIBAVIRIN IN NONRESPONDERS WITH HCV-RNA GENOTYPE-1, Hepatology, 28(4), 1998, pp. 489-489

Authors: VUCELIC B PELTEKIAN K LAURIE Y VAFIADES I STALGIS C
Citation: B. Vucelic et al., 4 WEEKS OF DAILY IFN PLUS RIBAVIRIN THERAPY IS INSUFFICIENT TO MAINTAIN VIRAL SUPPRESSION IN HCV-RNA GENOTYPE-1 PATIENTS, Hepatology, 28(4), 1998, pp. 490-490

Authors: STALGIS C MCHUTCHISON J BEKKERING F PERELSON AS
Citation: C. Stalgis et al., PREDICTION OF EARLY VIRAL CLEARANCE WITH DAILY IFN-MODEL(RIB USING A MATHEMATICAL), Hepatology, 28(4), 1998, pp. 941-941

Authors: TSANTOULAS D VAFIADES J KRONBORG I LURIE Y VECELIC B STALGIS C
Citation: D. Tsantoulas et al., 4 WEEKS OF DAILY THERAPY WITH IFN-ALPHA-2B PLUS RIBAVIRIN FOLLOWED BYSTANDARD THERAPY IN GENOTYPE-3 - RESULTS AT 12 WEEKS, Hepatology, 28(4), 1998, pp. 1263-1263

Authors: BUTI M OLIVE G ESTEBAN JJ STALGIS C DORAN Z ESTEBAN R
Citation: M. Buti et al., GENOTYPE-1 NONRESPONDER PATIENTS TREATED WITH HIGH DAILY IFN-ALPHA 2BPLUS RIBAVIRIN (R) DOSES ACHIEVE RAPID AND PROFOUND VIRAL REDUCTION, Hepatology, 26(4), 1997, pp. 351-351

Authors: HADZIYANNIS SJ TSANTOULAS D RAPTOPOULOU M KITIS G VAFIADES E TASSOPOULOS NC AREIAS J MA M STEFFEN M VOGEL W STALGIS C DORAN Z GLUE P
Citation: Sj. Hadziyannis et al., INDUCTION DOSING WITH INTERFERON-ALPHA-2B - AN INTERNATIONAL STUDY, Hepatology, 26(4), 1997, pp. 1166-1166

Authors: BAKER GA JACOBY A BUCK D STALGIS C MONNET D
Citation: Ga. Baker et al., QUALITY-OF-LIFE OF PEOPLE WITH EPILEPSY - A EUROPEAN STUDY, Epilepsia, 38(3), 1997, pp. 353-362
Risultati: 1-8 |